Home › Drug Product Listings

Drug Product Listings

Please note - this is not a complete list of products available in Canada. For a complete list of drug products marketed in Canada, visit the Health Canada Drug Product Database
A (5) | B (2) | C (4) | D (4) | E (8) | F (1) | G (4) | I (3) | L (3) | N (1) | O (2) | P (2) | R (1) | S (6) | T (7) | U (1) | V (1) | W (2)
Generic Namesort icon Common Trade Name(s) Classification Date Marketed in Canada (yyyy/mm/dd)
White birch extract (Betula verrucosa) Itulatek Allergy immunotherapy 2020/09/28
Warfarin Coumadin Anticoagulant 2020/04/23
Voretigene Luxturna Cellular and gene therapy 2020/10/13
Ulipristal Fibristal Selective progesterone receptor modulator (SERM)
Tucatinib Tukysa Antineoplastic agent 2020/10/08
Trastuzumab deruxtecan Enhertu Antineoplastic agent 2021/04/15
Tibolone Tibella Hormone replacement therapy 2020/07/29
Teriparatide Osnuvo Bone formation agent 2020/10/27
Tepotinib Tepmetko Protein kinase inibitor (antineoplastic agent)
Tenapanor Ibsrela Sodium/hydrogen exchanger inhibitor 2020/11/23
Tafamidis Vyndaqel Selective stabilizer of transthyretin - cardiac drug 2020/04/07
Sumatriptan + naproxen Suvexx Serotonin receptor agonist + NSAID 2020/07/24
Sonidegib Odomzo Antineoplastic agent 2020/06/11
Sodium zirconium cyclosilicate Lokelma Potassium binder 2019/10/17
Siponimod Mayzent Immunomodulatory agent 2020/04/24
Semaglutide Rybelsus Incretin mimetic 2020/04/19
Satralizumab Enspryng Immunosuppresant 2020/08/26
Ribociclib Kisqali Antineoplastic agent 2018/11/26
Ponesimod Ponvory Sphingosine 1-phosphate receptor modulator 2021/04/28
Patiromer Veltassa Potassium binder 2020/03/09
Onasemnogene Zolgensma Cellular and gene therapy 2021/02/04
Ofatumumab Kesimpta Immunomudulator 2021/04/08
Niraparib Zejula Antineoplastic agent 2020/01/09
Lorlatinib Lorbrena Tyrosine kinase inhibitor 2019/04/22
Lemborexant Dayvigo Hypnotic 2020/11/06
Larotrectinib Vitrakvi Antineoplastic agent 2019/07/10
Isatuximab Sarclisa Antineoplastic agent, monoclonal antibody 2020/07/03
Infliximab Avsola Biological response modifier 2020/06/01
Indacaterol + glycopyrronium bromide + mometasone Enerzair Breezhaler Asthma medication 2020/11/05
Glucagon Baqsimi Hyperglycemic agent 2019/11/20
Glasdegib Daurismo Antineoplastic agent 2020/08/10
Gilteritinib Xospata Antineoplastic agent 2020/02/03
Galcanezumab Emgality CGRP binding antibody 2019/10/02
Fremanezumab Ajovy Anti-calcitonin gene-related peptide 2020/08/04
Etonogestrel Nexplanon Hormonal contraceptive 2020/08/17
Eszopiclone Lunesta Hypnotic 2020/10/20
Syndicate content